NCT00893880

A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 92 (actual)
• Sponsor: Nitric BioTherapeutics, Inc · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

A multi-arm trial to evaluate the efficacy and safety of using gaseous nitric oxide to treat moderate to severe tinea pedis.

Conditions

• Tinea Pedis

Interventions

Type	Name	Description
DRUG	1% gaseous Nitric Oxide blended in Oxygen	1% gaseous nitric oxide blended in oxygen applied for 30-60 minutes over 1-2 consecutive days.

Timeline

• Start date: 2009-06-01
• Primary completion: 2010-01-01
• Completion: 2010-05-01
• First posted: 2009-05-06
• Last updated: 2012-10-22

Locations

4 sites across 2 countries: Canada, Saint Kitts and Nevis